BIM
FOLD

BlackRock Investment Management’s Amicus Therapeutics FOLD Stock Holding History

BlackRock Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.62M Buy
527,430
+38
+0% +$263 ﹤0.01% 2033
2016
Q3 		$3.9M Buy
527,392
+55,337
+12% +$374K ﹤0.01% 1663
2016
Q2 		$2.58M Buy
472,055
+75,820
+19% +$530K ﹤0.01% 1914
2016
Q1 		$3.35M Buy
396,235
+6,061
+2% +$42.9K ﹤0.01% 1646
2015
Q4 		$3.79M Buy
390,174
+1,887
+0.5% +$17K ﹤0.01% 1597
2015
Q3 		$5.43M Buy
388,287
+60,952
+19% +$956K 0.01% 1325
2015
Q2 		$4.63M Buy
327,335
+316,879
+3,031% +$3.81M 0.01% 1560
2015
Q1 		$114K Buy
10,456
+136
+1% +$1.2K ﹤0.01% 3289
2014
Q4 		$86K Buy
10,320
+1,684
+19% +$11.6K ﹤0.01% 3335
2014
Q3 		$51K Buy
8,636
+1,772
+26% +$9.28K ﹤0.01% 3322
2014
Q2 		$23K Sell
6,864
-80,663
-92% -$189K ﹤0.01% 3367
2014
Q1 		$181K Sell
87,527
-1,223
-1% -$3.06K ﹤0.01% 3245
2013
Q4 		$209K Buy
88,750
+437
+0.5% +$959 ﹤0.01% 3213
2013
Q3 		$205K Buy
88,313
+3,138
+4% +$7.87K ﹤0.01% 3183
2013
Q2 		$198K Buy
+85,175
New +$262K ﹤0.01% 3166

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BlackRock Investment Management's FOLD Position: Q4 2016 in Review

BlackRock Investment Management increased its Amicus Therapeutics (FOLD) stake by 0.01% in Q4 2016, buying an estimated $263 and bringing the position to 527,430 shares worth $2.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2033.

BlackRock Investment Management first reported a position in FOLD in Q2 2013 and has held it in 15 quarters since. The position peaked at $5.43M in Q3 2015. 135 funds tracked by Wall St. Rank hold FOLD as of Q4 2016.

  • BlackRock Investment Management held 527,430 shares of Amicus Therapeutics worth $2.62M as of Q4 2016.
  • BlackRock Investment Management bought 38 Amicus Therapeutics shares in Q4 2016, an estimated $263.
  • Amicus Therapeutics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2033 holding.
  • BlackRock Investment Management first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Amicus Therapeutics position peaked at $5.43M in Q3 2015.
  • 135 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.